Hong Kong, China vs Senegal: Previously treated cases tested for RR-/MDR-TB
Hong Kong, China
87.0%
in 2024
Senegal
87.0%
in 2024
Hong Kong, China rank
92nd
Senegal rank
92nd
Previously treated cases tested for RR-/MDR-TB over time
- Hong Kong, China
- Senegal
How they compare
Hong Kong, China currently reports 87.0% against 87.0% in Senegal, a difference of 0.0%.
The two have swapped places 5 times across 17 shared years of data; in 2007 it was Hong Kong, China ahead.
Hong Kong, China ranks 92nd and Senegal ranks 92nd of 180 countries.
Across the 3 decades both report, Hong Kong, China averaged higher in 2 and Senegal in 1.
Head to head by decade
| Decade | Hong Kong, China | Senegal | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 53.3% | 3.0% | 50.3% | Hong Kong, China |
| 2010s | 59.6% | 57.1% | 2.4% | Hong Kong, China |
| 2020s | 87.8% | 88.6% | 0.8% | Senegal |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Hong Kong, China or Senegal?
- Hong Kong, China, at 87.0% against 87.0% in Senegal as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Hong Kong, China and Senegal?
- 0.0%, with Hong Kong, China ahead.
- How many years of comparable data are there for Hong Kong, China and Senegal?
- 17 years are reported by both, from 2007 to 2024.
- How do Hong Kong, China and Senegal rank globally for previously treated cases tested for rr-/mdr-tb?
- Hong Kong, China ranks 92nd and Senegal ranks 92nd of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.